Details for Patent: 5,234,956

Title:	Method of preventing NMDA receptor complex-mediated neuronal damage
Abstract:	Disclosed is a method for reducing NMDA receptor-mediated neuronal damage in a mammal by administering to the mammal a nitric-oxide generating compound, or a physiologically acceptable salt thereof, in a concentration effective to cause such reduction. Also disclosed is a method for reducing NMDA receptor-mediated neuronal damage in a mammal by administering to the mammal nitroprusside, nitroglycerin, or a derivative of one of those compounds, in a concentration effective to cause such reduction.
Inventor(s):	Lipton; Stuart A. (Newton, MA)
Assignee:	The Children's Medical Center Corporation (Boston, MA)
Filing Date:	Sep 22, 1992
Application Number:	07/949,342
Claims:	1. A method for reducing NMDA receptor-mediated neuronal damage in a human comprising reducing the NMDA-mediated increase in the intraneuronal concentration by administering to said human a compound selected from the group consisting of: a) nitroprusside, b) nitroglycerin, c) an NO-generating derivative of nitroprusside or nitroglycerin, or d) a physiologically acceptable salt of a)-c), above, in a concentration effective to cause such reduction. 2. The method of claim 1, wherein said compound is nitroprusside or a physiologically acceptable salt thereof. 3. The method of claim 1, wherein said compound is nitroglycerine or a physiologically acceptable salt thereof. 4. The method of claim 1, wherein said compound is nitroprusside or an NO-generating derivative thereof. 5. The method of claim 1, wherein said compound is nitroglycerin or an NO-generating derivative thereof. 6. The method of any of claims 1-5, wherein said human is infected with a human immunodeficiency virus. 7. The method of claim 6, wherein said human manifests symptoms of the AIDS related complex or acquired immunodeficiency syndrome. 8. The method of any of claims 1-5 wherein said human suffers from a disorder selected from the group consisting of hypoxia, ischemia, trauma, hypoglycemia, seizures, stroke, Alzheimer's disease, Huntington's disease, or Parkinson's disease. 9. A method for controlling neuronal damage associated with a disorder selected from the group consisting of hypoxia, ischemia, trauma, hypoglycemia, seizures, stroke, Alzheimer's disease, Huntington's disease, Parkinson's disease, and infection with Human Immunodeficiency Virus (HIV), said method comprising administering to a patient: a) nitroglycerin, b) nitroprusside, c) an NO-generating derivative of a) or b), or d) a physiologically acceptable salt of a)-c). 10. The method claim 9 wherein said disorder is infection with HIV. 11. The method claim 9 wherein said disorder is hypoxia or ischemia. 12. The method of claim 9, claim 10 or claim 11 comprising administering nitroglycerin or a physiologically acceptable salt thereof to said patient. 13. The method of claim 9, claim 10 or claim 11 comprising administering nitroprusside or a physiologically acceptable salt thereof to said patient.